$116.48
Insights on Ensign Group Inc
Revenue is up for the last 12 quarters, 627.25M → 980.37M (in $), with an average increase of 4.0% per quarter
Netprofit is down for the last 3 quarters, 63.99M → 21.69M (in $), with an average decrease of 33.1% per quarter
In the last 1 year, Davita Healthcare Partners Inc. has given 52.9% return, outperforming this stock by 32.8%
0.67%
Downside
Day's Volatility :2.05%
Upside
1.39%
25.52%
Downside
52 Weeks Volatility :31.93%
Upside
8.61%
Period | Ensign Group Inc | Sector (Health Care) | Index (Russel 2000) |
---|---|---|---|
3 Months | 1.57% | -0.7% | 0.0% |
6 Months | 20.46% | 6.6% | 0.0% |
1 Year | 20.07% | 3.7% | -1.5% |
3 Years | 33.51% | 14.0% | -21.8% |
Market Capitalization | 6.8B |
Book Value | $26.57 |
Dividend Share | 0.233 |
Dividend Yield | 0.2% |
Earnings Per Share (EPS) | 3.65 |
PE Ratio | 32.24 |
PEG Ratio | 1.48 |
Wall Street Target Price | 133.25 |
Profit Margin | 5.61% |
Operating Margin TTM | 2.33% |
Return On Assets TTM | 4.18% |
Return On Equity TTM | 15.28% |
Revenue TTM | 3.7B |
Revenue Per Share TTM | 66.94 |
Quarterly Revenue Growth YOY | 21.099999999999998% |
Gross Profit TTM | 534.9M |
EBITDA | 326.6M |
Diluted Eps TTM | 3.65 |
Quarterly Earnings Growth YOY | -0.65 |
EPS Estimate Current Year | 5.39 |
EPS Estimate Next Year | 5.9 |
EPS Estimate Current Quarter | 1.27 |
EPS Estimate Next Quarter | 1.25 |
What analysts predicted
Upside of 14.4%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 2.1B | ↑ 12.12% |
Net Income | 92.4M | ↑ 128.2% |
Net Profit Margin | 4.45% | ↑ 2.26% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 2.0B | ↓ 1.78% |
Net Income | 110.5M | ↑ 19.67% |
Net Profit Margin | 5.43% | ↑ 0.98% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 2.4B | ↑ 17.98% |
Net Income | 170.5M | ↑ 54.23% |
Net Profit Margin | 7.1% | ↑ 1.67% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 2.6B | ↑ 9.36% |
Net Income | 194.7M | ↑ 14.18% |
Net Profit Margin | 7.41% | ↑ 0.31% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 3.0B | ↑ 15.15% |
Net Income | 224.7M | ↑ 15.43% |
Net Profit Margin | 7.43% | ↑ 0.02% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 3.7B | ↑ 23.27% |
Net Income | 209.4M | ↓ 6.8% |
Net Profit Margin | 5.61% | ↓ 1.82% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Revenue | 770.0M | ↑ 5.12% |
Net Income | 56.2M | ↓ 2.62% |
Net Profit Margin | 7.3% | ↓ 0.58% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 809.5M | ↑ 5.13% |
Net Income | 60.5M | ↑ 7.64% |
Net Profit Margin | 7.47% | ↑ 0.17% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 886.8M | ↑ 9.55% |
Net Income | 59.9M | ↓ 1.02% |
Net Profit Margin | 6.75% | ↓ 0.72% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 921.3M | ↑ 3.89% |
Net Income | 64.0M | ↑ 6.92% |
Net Profit Margin | 6.95% | ↑ 0.2% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 940.8M | ↑ 2.11% |
Net Income | 63.9M | ↓ 0.2% |
Net Profit Margin | 6.79% | ↓ 0.16% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 980.4M | ↑ 4.21% |
Net Income | 21.7M | ↓ 66.04% |
Net Profit Margin | 2.21% | ↓ 4.58% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 1.2B | ↑ 7.21% |
Total Liabilities | 579.6M | ↓ 3.78% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 2.4B | ↑ 99.83% |
Total Liabilities | 1.7B | ↑ 194.29% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 2.5B | ↑ 7.78% |
Total Liabilities | 1.7B | ↑ 1.27% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 2.9B | ↑ 11.98% |
Total Liabilities | 1.8B | ↑ 5.88% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 3.5B | ↑ 21.1% |
Total Liabilities | 2.2B | ↑ 20.47% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 4.2B | ↑ 21.02% |
Total Liabilities | 2.7B | ↑ 21.65% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 3.3B | ↑ 4.5% |
Total Liabilities | 2.1B | ↑ 3.97% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 3.5B | ↑ 5.72% |
Total Liabilities | 2.2B | ↑ 5.74% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 3.9B | ↑ 11.88% |
Total Liabilities | 2.5B | ↑ 15.4% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 4.0B | ↑ 2.33% |
Total Liabilities | 2.6B | ↑ 0.65% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 4.1B | ↑ 3.28% |
Total Liabilities | 2.6B | ↑ 2.25% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 4.2B | ↑ 2.34% |
Total Liabilities | 2.7B | ↑ 2.43% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 210.3M | ↑ 188.27% |
Investing Cash Flow | -151.2M | ↑ 41.86% |
Financing Cash Flow | -70.3M | ↓ 484.99% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 168.9M | ↓ 19.67% |
Investing Cash Flow | -247.0M | ↑ 63.36% |
Financing Cash Flow | 83.3M | ↓ 218.39% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 373.4M | ↑ 121.01% |
Investing Cash Flow | -58.7M | ↓ 76.25% |
Financing Cash Flow | -137.3M | ↓ 264.87% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 275.7M | ↓ 26.16% |
Investing Cash Flow | -173.9M | ↑ 196.44% |
Financing Cash Flow | -76.1M | ↓ 44.55% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 272.5M | ↓ 1.15% |
Investing Cash Flow | -186.2M | ↑ 7.06% |
Financing Cash Flow | -32.3M | ↓ 57.63% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 92.5M | ↑ 10.23% |
Investing Cash Flow | -67.2M | ↑ 136.9% |
Financing Cash Flow | -2.1M | ↓ 88.87% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 50.2M | ↓ 45.77% |
Investing Cash Flow | -42.4M | ↓ 36.86% |
Financing Cash Flow | -359.0K | ↓ 82.62% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 48.3M | ↓ 3.65% |
Investing Cash Flow | -36.0M | ↓ 15.18% |
Financing Cash Flow | -1.7M | ↑ 366.3% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 119.7M | ↑ 147.68% |
Investing Cash Flow | -26.5M | ↓ 26.43% |
Financing Cash Flow | -269.0K | ↓ 83.93% |
Sell
Neutral
Buy
Ensign Group Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Ensign Group Inc | -3.58% | 20.46% | 20.07% | 33.51% | 161.12% |
Fresenius Medical Care Ag | -0.32% | 10.42% | -15.35% | -50.85% | -51.82% |
Hca Holdings, Inc. | -4.93% | 28.25% | 14.58% | 59.59% | 169.9% |
Tenet Healthcare Corp. | -4.36% | 72.26% | 44.71% | 82.68% | 310.08% |
Universal Health Services Inc. | -9.74% | 24.99% | 16.98% | 9.58% | 28.53% |
Davita Healthcare Partners Inc. | -6.85% | 62.1% | 52.88% | 15.22% | 144.38% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Ensign Group Inc | 32.24 | 32.24 | 1.48 | 5.39 | 0.15 | 0.04 | 0.0 | 26.57 |
Fresenius Medical Care Ag | 20.44 | 20.44 | 0.39 | 2.04 | 0.05 | 0.03 | 0.03 | 46.42 |
Hca Holdings, Inc. | 17.0 | 17.0 | 1.44 | 20.64 | 0.12 | 0.11 | 0.01 | -6.68 |
Tenet Healthcare Corp. | 17.21 | 17.21 | 2.2 | 6.03 | 0.26 | 0.06 | NA | 16.09 |
Universal Health Services Inc. | 16.27 | 16.27 | 1.87 | 13.45 | 0.12 | 0.05 | 0.0 | 91.53 |
Davita Healthcare Partners Inc. | 17.49 | 17.49 | 1.16 | 9.01 | 0.39 | 0.06 | NA | 11.89 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Ensign Group Inc | Buy | $6.8B | 161.12% | 32.24 | 5.61% |
Fresenius Medical Care Ag | Hold | $10.9B | -51.82% | 20.44 | 2.57% |
Hca Holdings, Inc. | Buy | $85.3B | 169.9% | 17.0 | 8.07% |
Tenet Healthcare Corp. | Buy | $9.7B | 310.08% | 17.21 | 2.97% |
Universal Health Services Inc. | Hold | $11.2B | 28.53% | 16.27 | 5.03% |
Davita Healthcare Partners Inc. | Hold | $11.3B | 144.38% | 17.49 | 5.7% |
BlackRock Inc
Vanguard Group Inc
Wasatch Advisors Inc.
Capital Research Global Investors
Fuller & Thaler Asset Management Inc
State Street Corporation
In the quarter ending March,2024. Ensign Group Inc has declared dividend of $0.06
Read Moreskilled nursing/assisted living
Organization | Ensign Group Inc |
Employees | 35300 |
CEO | Mr. Christopher R. Christensen |
Industry | Health Services |
Endeavor Group Holdings, Inc.
$116.48
-1.14%
Associated Banc-corp
$116.48
-1.14%
Assetmark Financial Holdings Inc
$116.48
-1.14%
Essential Utilities Inc.
$116.48
-1.14%
Vanguard Ultra Short Bond Et
$116.48
-1.14%
Surgery Partners Inc
$116.48
-1.14%
Sl Green Realty Corp.
$116.48
-1.14%
Janus Henderson Mortgage-backed Securities Etf
$116.48
-1.14%
Goldman Sachs Activebeta Int
$116.48
-1.14%